Benitec Biopharma Inc. (BNTC)
Nasdaq: BNTC · Pharmaceutical Preparations · Hayward, CA · filing with the SEC since 2020
Who owns Benitec Biopharma Inc.
As filed with the SECHolders of 5% or more
4
Suvretta Capital Management, LLC holds 44.1% of Common Stock, par value $0.0001, as its SCHEDULE 13D/A filed Nov 10, 2025 says.
Directors and officers
13
report now, of 13 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Suvretta Capital Management, LLC
SCHEDULE 13D/A · filed Nov 10, 2025 · Common Stock, par value $0.0001 · 49.9% in Mar 28, 2025
Franklin Resources, Inc.
SCHEDULE 13G/A · filed Jan 29, 2026 · Common Stock, par value $0.0001 · 14.9% in Nov 4, 2025
Janus Henderson Group PLC
SCHEDULE 13G/A · filed Dec 8, 2025 · Common Stock · 11.3% in Aug 14, 2025
RA Capital Management, L.P.
SCHEDULE 13G · filed Dec 3, 2025 · Common Stock, par value $0.0001 per share
HBM Healthcare Investments (Cayman) Ltd.
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, par value $0.0001 · reported falling below 5%, from 9.65% in Nov 14, 2024
What BNTC reports owning in othersstakes of 5% or more, and other ties
8 subsidiaries in 3 countries, from the list filed with the 10-K filed Sep 14, 2026.
Insider tradesForm 4
0sales
14purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$22.4Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 17 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Averill Madison Master Fund, Ltd. | director | 0 | $0 | 0 | 6 | $500,000 |
| Cowen Aaron | director | 0 | $0 | 0 | 6 | $1.9M |
| Suvretta Capital Management, LLC | director | 0 | $0 | 0 | 2 | $20.0M |